Cannabis affects your eyes in ways that go well beyond the stereotypical bloodshot look. THC and other cannabinoids interact with receptors spread throughout the eye, from the cornea to the retina, triggering a cascade of changes to tear production, pupil response, intraocular pressure, and even how your retina processes light. Some of these effects are harmless and temporary, while others carry real implications for eye health and visual safety.
Why Cannabis Turns Your Eyes Red
The telltale red-eye effect is the single most recognized sign of cannabis use, and it happens because of a straightforward vascular reaction. THC binds to cannabinoid receptors in the eye’s blood vessels, causing them to widen. This vasodilation increases blood flow to the conjunctiva, the thin membrane covering the white of the eye, making the tiny vessels there more visible. The effect is dose-dependent: the more THC in your system, the redder your eyes get.1PubMed Central. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review
This is worth knowing because it means the redness has nothing to do with smoke irritation. Edibles, vapes, and other smoke-free methods cause the same bloodshot look. Over-the-counter eye drops containing vasoconstrictors (the “get the red out” type) can counteract it temporarily by squeezing the blood vessels back down, but the redness resolves on its own as THC clears your system.
Dry Eyes and Reduced Tear Production
If your eyes feel dry or gritty after using cannabis, it’s not your imagination. Research in mice has shown that THC significantly reduces tear volume, and this effect is mediated by the same cannabinoid receptors responsible for the redness. In one study, THC-treated male mice showed tear volumes roughly 60% lower than untreated controls, consistent with the reduced tearing observed in human cannabis users.2PubMed Central. THC Regulates Tearing via Cannabinoid CB1 Receptors
For occasional users, this is a minor nuisance solved with artificial tears. But anyone who already deals with dry eye disease should be aware that cannabis can make it worse. The combination of vasodilation (which changes the fluid dynamics on the eye’s surface) and reduced tear output creates conditions that may accelerate the discomfort and corneal irritation that come with chronic dry eye.
What THC Does to Your Pupils
Cannabis also changes how your pupils respond to light, though the effects are subtler than the redness. In a placebo-controlled trial of healthy volunteers who received intravenous THC, the pupils showed measurably weakened light reflexes. The relative amplitude of the pupil’s constriction dropped from about 23.5% to 15% within 20 minutes of THC administration, while the placebo group stayed stable. Constriction time shortened, and the overall contraction amplitude shrank as well. Pupil size itself actually decreased after THC.3PubMed Central. Effects of intravenous d9-THC on pupillary reaction and pupil size: a prospective, placebo-controlled trial in healthy volunteers not regularly consuming cannabis
A separate study using smartphone-based pupillography confirmed the pattern, finding that acute cannabis smoking was associated with less initial and sustained pupil constriction in response to light compared to no cannabis use.4PubMed Central. A Study of Pupil Response to Light as a Digital Biomarker of Recent Cannabis Use These pupil changes are increasingly being explored as a potential biomarker for detecting recent cannabis use, which could have implications for roadside impairment testing.
How Vision Changes While You’re High
Beyond the cosmetic signs, cannabis measurably alters how well you see. A study that tested participants before and after smoking cannabis found that intraocular straylight increased by roughly 9% after use. Straylight is the scattering of light inside the eye, and when it goes up, you perceive more halos around light sources, particularly at night or in low-light conditions. Participants in this study saw more halos and had higher visual disturbance scores, even though their pupil size hadn’t changed between conditions.5PubMed Central. Effects of cannabis on visual function and self-perceived visual quality
At the retinal level, acute cannabis use can temporarily disrupt how photoreceptors function. One case study measured a drop of up to 48% in a specific component of the eye’s electrical response to light (the a-wave of the full-field electroretinogram) just 30 minutes after cannabis smoking. These changes resolved within hours, but they suggest that THC directly interferes with how photoreceptor cells process incoming light.6PubMed. Transient Retinal Dysfunctions after Acute Cannabis Use
A systematic review of oculomotor effects found that the evidence on smooth pursuit eye movements, the kind you use to track a moving object, is mixed. Some trials found that THC impaired smooth pursuit, reducing the percentage of time spent in smooth tracking and lowering pursuit speeds. Others found no difference from placebo.7PubMed Central. A systematic review of oculomotor deficits associated with acute and chronic cannabis use The inconsistency likely reflects differences in dosing and individual tolerance, but the fact that some studies show impairment is relevant for tasks that demand precise eye tracking.
The Curious Case of Night Vision
Here’s where the story gets counterintuitive. Despite the increased straylight and photoreceptor disruption described above, there is evidence that cannabinoids can actually improve aspects of night vision. A field study of traditional cannabis smokers in Morocco’s Rif Mountains found improvements in dark adaptation measurements after THC use, suggesting the effect was dose-dependent and mediated at the retinal level.8PubMed. Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco
A 2024 study in rats helped explain the mechanism. Under dark-adapted conditions, activating cannabinoid receptors significantly boosted the amplitude of the retinal signals responsible for dim-light processing. The researchers traced this to a specific retinal circuit where cannabinoid receptor activation increases signal gain in the inner retina, essentially amplifying weak light signals. The effect kicked in within about 15 minutes and lasted up to 45 minutes.9PubMed Central. Non-canonical type 1 cannabinoid receptor signaling regulates night visual processing in the inner rat retina
So cannabis appears to simultaneously worsen some visual functions (straylight, halos, photoreceptor response) while enhancing others (dim-light signal processing). These aren’t contradictory: they happen through different pathways in different parts of the visual system. The practical upshot is that you shouldn’t count on improved night vision to offset the other visual impairments, especially since halo perception makes nighttime driving conditions worse regardless of how well your retina detects dim light.
Cannabis, Vision, and Driving
The visual changes from cannabis are not abstract. They translate directly into impaired driving performance. A driving-simulator study found that cannabis-induced worsening of stereoscopic depth perception, visual acuity, and contrast sensitivity all correlated with worse driving outcomes, including greater lane deviation and more frequent shoulder incursions. The strongest link was between impaired depth perception and drifting off the road on curving mountain roads.10PubMed Central. Effects of Smoking Cannabis on Visual Function and Driving Performance. A Driving-Simulator Based Study
A follow-up comparison of cannabis and alcohol effects confirmed the connection: visual function impairment after cannabis was significantly associated with worse driving performance.11PubMed. Comparison of the effects of alcohol and cannabis on visual function and driving performance. Does the visual impairment affect driving? The fact that depth perception is the most affected visual function is particularly concerning for driving, since judging distances is essential for maintaining lane position, following other vehicles, and navigating curves.
Why Cannabis Is Not a Glaucoma Treatment
One of the most persistent myths about cannabis and eye health is that it’s useful for treating glaucoma. The kernel of truth is that cannabinoids do lower intraocular pressure, and the mechanism is well understood. Cannabinoid receptors are present in the tissues that produce and drain the eye’s internal fluid, including the ciliary body and the trabecular meshwork.12PubMed. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues Activating these receptors can both reduce fluid production and improve drainage, lowering the pressure inside the eye.13PubMed Central. Role of Endocannabinoids in Glaucoma: A Review
The problem is that the pressure drop is short-lived, typically lasting only a few hours. Glaucoma requires around-the-clock pressure control, which would mean using cannabis every few hours throughout the day, a regimen that carries significant side effects and the risk of dependence.14PubMed Central. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? Multiple reviews have concluded that the available evidence is inadequate to recommend cannabinoids for routine glaucoma treatment, and that the harmful effects outweigh the benefits for most patients.15PubMed Central. Cannabinoids for the Treatment of Glaucoma: A Review
There is an interesting wrinkle involving CBD specifically. While THC lowers eye pressure, one study in mice found that CBD actually raised intraocular pressure at standard doses. The effect appears to be mediated by cannabinoid receptors in a way that opposes THC’s action. In mice lacking CB1 receptors, CBD instead lowered pressure, suggesting CBD has two competing effects and the pressure-raising one normally dominates.16PubMed Central. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure This is an early animal finding, but it’s worth knowing if you’re considering CBD products and you have or are at risk for glaucoma.
That said, research on the neuroprotective potential of cannabinoids in glaucoma continues. The CB2 receptor in particular has shown anti-inflammatory and cell-protective properties that could theoretically help shield the optic nerve from glaucoma damage, though this is a long way from being a treatment option.17PubMed Central. Therapeutic Potential of Cannabinoids in Glaucoma
Visual Snow and Persisting Visual Disturbances
A less common but more alarming eye-related consequence of cannabis use involves lasting changes to visual perception. Visual snow syndrome involves seeing a constant overlay of tiny flickering dots, like static on an old television, along with other visual disturbances such as afterimages and light sensitivity. While this condition is most often linked to classical hallucinogens, there are case reports connecting it to cannabis. One documented case involved a 26-year-old man who developed visual snow syndrome after consuming less than half of a delta-8 THC gummy, at an estimated dose of only about 4 milligrams.18PubMed Central. Delta-8 gummies causing visual snow: a case report
A separate case report described a boy who developed hallucinogen-persisting perception disorder, a related condition involving visual disturbances that continue long after the drug has cleared the body, after using cannabis only seven times.19Progress in Neurology and Psychiatry. A persisting perception disorder after cannabis use These are individual case reports, not large studies, so the actual risk is unclear and likely very low. But they establish that cannabis can, in rare instances, trigger lasting visual perception changes that persist well beyond the period of intoxication.
Prenatal Cannabis Exposure and Developing Eyes
Cannabis use during pregnancy raises separate concerns for the developing visual system. A study of toddlers found that prenatal marijuana exposure throughout pregnancy, but not exposure limited to the first trimester alone, predicted a roughly two-fold increased likelihood of unusual visual sensory processing behaviors, such as excessively seeking out visual stimulation. This association held after controlling for other prenatal exposures.20PubMed Central. Prenatal marijuana exposure and visual perception in toddlers: Evidence of a sensory processing deficit
Longer-term data from a large adolescent brain development study found that prenatal cannabis exposure was associated with gradually worsening visual-perceptual processing ability over time, suggesting the effects may become more pronounced as children grow older rather than fading with development.21PubMed Central. Effects of prenatal cannabis exposure on developmental trajectory of cognitive ability and brain volumes in the adolescent brain cognitive development (ABCD) study Animal research has corroborated these findings, showing structural thinning of retinal layers in offspring exposed to cannabis smoke during gestation, with the thinning worsening over time even after exposure stopped. Together, these lines of evidence suggest that the developing visual system is particularly vulnerable to cannabinoid exposure, and that the consequences may not be fully apparent until years after birth.
Why Cannabinoid Eye Drops Are So Hard to Make
Given all the ways cannabinoids interact with the eye, there’s obvious interest in developing cannabinoid-based eye drops, whether for lowering eye pressure, reducing inflammation, or promoting corneal wound healing. The obstacle is chemistry. THC and CBD are extremely lipophilic, meaning they strongly resist dissolving in water-based solutions like tears. Getting them to penetrate the eye’s multiple biological barriers through a topical drop has proven remarkably difficult.22PubMed Central. Cannabinoid-Based Ocular Therapies and Formulations
Researchers have explored various delivery systems to solve this problem, including solid lipid nanoparticles and thin films designed to improve penetration of THC analogs into deeper eye tissues.23PubMed Central. Ocular Disposition of Δ8-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations For CBD specifically, nanoemulsion formulations have shown promise for anti-inflammatory and wound-healing applications on the corneal surface, though CBD’s chemical instability and rapid metabolism remain hurdles.24PubMed. Cannabidiol nanoemulsion for eye treatment – Anti-inflammatory, wound healing activity and its bioavailability using in vitro human corneal substitute None of these formulations are close to being available to patients. The challenge is not a lack of interesting biological targets in the eye but a fundamental drug delivery problem that has not yet been solved.
Cannabinoid Receptors Are Everywhere in the Eye
A useful piece of context for understanding all of these effects is just how densely the eye is wired with cannabinoid receptors. Mapping studies in human tissue have found CB1 receptors throughout the front of the eye, including the corneal surface layers, the ciliary body that produces intraocular fluid, the trabecular meshwork that drains it, and the muscle that controls lens focusing. In the retina, CB1 receptors show up in the synaptic layers where visual signals are processed, in the ganglion cells that send signals to the brain, and strongly in the outer segments of photoreceptors themselves.25PubMed. Localization of cannabinoid CB1 receptors in the human anterior eye and retina
This distribution explains why the eye is so responsive to cannabinoids from so many angles: redness from blood vessel receptors, pressure changes from drainage-tissue receptors, tear reduction from gland-associated receptors, vision changes from retinal receptors. The eye is, in a sense, one of the most cannabinoid-sensitive organs in the body. It also explains why the dream of a single cannabinoid eye drop that hits one target without affecting the others is so difficult to realize. When receptors are everywhere, selectivity becomes a serious engineering problem.